Brain Proteomics

265

[13] E. M. Cilento, L. Jin, T. Stewart, et al., “Mass spectrometry: A platform

for biomarker discovery and validation for alzheimer’s and parkinson’s

diseases,” Journal of neurochemistry, vol. 151, no. 4, pp. 397–416, 2019.

[14] P. C. Guest, “Proteomic studies of psychiatric disorders,” Investigations

of Early Nutrition Effects on Long-Term Health: Methods and Applica-

tions, pp. 59–89, 2018.

[15] A. G. Woods, I. Sokolowska, A. G. Ngounou Wetie, et al., “Mass spec-

trometry for proteomics-based investigation,” Advancements of Mass

Spectrometry in Biomedical Research, pp. 1–26, 2019.

[16] T. Sajic, Y. Liu, and R. Aebersold, “Using data-independent, high-

resolution mass spectrometry in protein biomarker research: perspectives

and clinical applications,” PROTEOMICS–Clinical Applications, vol. 9,

no. 3-4, pp. 307–321, 2015.

[17] A. Bilbao, E. Varesio, J. Luban, et al., “Processing strategies and soft-

ware solutions for data-independent acquisition in mass spectrometry,”

Proteomics, vol. 15, no. 5-6, pp. 964–980, 2015.

[18] O. Karayel, S. V. Winter, S. Padmanabhan, et al., “Proteome profiling of

cerebrospinal fluid reveals biomarker candidates for parkinson’s disease,”

Cell Reports Medicine, vol. 3, no. 6, 2022.

[19] L. Ping, D. M. Duong, L. Yin, et al., “Global quantitative analysis of the

human brain proteome in alzheimer’s and parkinson’s disease,” Scientific

data, vol. 5, no. 1, pp. 1–12, 2018.

[20] T. Välikangas, T. Suomi, and L. L. Elo, “A comprehensive evaluation

of popular proteomics software workflows for label-free proteome quan-

tification and imputation,” Briefings in bioinformatics, vol. 19, no. 6,

pp. 1344–1355, 2018.

[21] C. Loureiro, M. A. R. Buzalaf, F. Moraes, et al., “Quantitative proteomic

analysis in symptomatic and asymptomatic apical periodontitis,” Inter-

national Endodontic Journal, vol. 54, no. 6, pp. 834–847, 2021.

[22] C. D. Wenger and J. J. Coon, “A proteomics search algorithm specifically

designed for high-resolution tandem mass spectra,” Journal of proteome

research, vol. 12, no. 3, pp. 1377–1386, 2013.

[23] S. Tyanova, T. Temu, and J. Cox, “The maxquant computational plat-

form for mass spectrometry-based shotgun proteomics,” Nature protocols,

vol. 11, no. 12, pp. 2301–2319, 2016.

[24] A. Palomba, M. Abbondio, G. Fiorito, et al., “Comparative evaluation

of maxquant and proteome discoverer ms1-based protein quantification

tools,” Journal of proteome research, vol. 20, no. 7, pp. 3497–3507, 2021.